Synthesis and biological evaluation of novel phenothiazine derivatives as non-peptide arginine vasopressin V2 receptor antagonists

被引:0
|
作者
Shuang Zhi [1 ]
Shuai Mu [1 ,2 ]
Ying Liu [2 ]
Min Gong [2 ]
Ping-Bao Wang [2 ]
Deng-Ke Liu [2 ]
机构
[1] School of Chemical Engineering and Technology,Tianjin University
[2] Tianjin Institute of Pharmaceutical Research
关键词
Arginine vasopressin V2 receptor; antagonist; Phenothiazine derivatives; Synthesis; Biological activities;
D O I
暂无
中图分类号
O626 [杂环化合物];
学科分类号
摘要
A series of novel phenothiazine derivatives was synthesized and tested for arginine vasopressin receptor antagonist activity.They were synthesized as novel arginine vasopressin receptor antagonists from phenothiazine as a scaffold via successive acylation,reduction and acylation reactions.Their structures were characterized by ~1H NMR,C NMR and HRMS,and biological activity was evaluated by in vitro and in vivo studies.The in vitro binding assay indicated that several compounds are potent selective V2 receptor antagonists.Compounds with promising binding affinity to V2 receptors were selected to conduct the in vivo diuretic studies on Sprague-Dawley rats.Among them.In,1r,1t and 1v exhibited excellent diuretic activity,especially 1 rand 1 v.Therefore,1r and 1v are potent novel AVPV2 receptor antagonist candidates.
引用
收藏
页码:627 / 630
页数:4
相关论文
共 50 条
  • [21] Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors
    Ge, Ying
    Li, Aibo
    Wu, Jianwei
    Feng, Haiwei
    Wang, Letian
    Liu, Hongwu
    Xu, Yungen
    Xu, Qingxiang
    Zhao, Li
    Li, Yuyan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 128 : 180 - 191
  • [22] Design, Synthesis and Biological Evaluation of Novel Non-peptide Boronic Acid Derivatives as Proteasome Inhibitors
    Zhang, Jiankang
    Shen, Luqing
    Wang, Jincheng
    Luo, Peihua
    Hu, Yongzhou
    MEDICINAL CHEMISTRY, 2014, 10 (01) : 38 - 45
  • [23] COMPARISON OF SELECTIVE ARGININE VASOPRESSIN V1 AND V2 RECEPTOR ANTAGONISTS ON BURN SHOCK IN THE RAT
    SUN, K
    LIN, BC
    WANG, CH
    ZHU, HN
    CARDIOVASCULAR RESEARCH, 1991, 25 (04) : 265 - 269
  • [25] Design and synthesis of amidino-tyrosine derivatives as non-peptide fibrinogen receptor antagonists
    Xu, TL
    Jiang, XT
    Hua, WY
    Ni, PZ
    Pei, YM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) : 1933 - 1936
  • [26] Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension
    Lacheretz, F
    Barbier, A
    Serradeil-Le Gal, C
    Elena, PP
    Maffrand, JP
    Le Fur, G
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2000, 16 (03) : 203 - 216
  • [27] Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor
    Cotte, N
    Balestre, MN
    Phalipou, S
    Hibert, M
    Manning, M
    Barberis, C
    Mouillac, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) : 29462 - 29468
  • [28] Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents
    Manning, Maurice
    Stoev, Stoytcho
    Chini, Bice
    Durroux, Thierry
    Mouillac, Bernard
    Guillon, Gilles
    ADVANCES IN VASOPRESSIN AND OXYTOCIN: FROM GENES TO BEHAVIOUR TO DISEASE, 2008, 170 : 473 - 512
  • [29] Synthesis and biological evaluation of novel isopropanolamine derivatives as non-peptide human immunodeficiency virus protease inhibitors
    Zhou, Lijun
    Yang, Qingang
    Wang, Yong
    Hu, Youhong
    Luo, Xiaomin
    Bai, Donglu
    Li, Shukun
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, 56 (08) : 1147 - 1152
  • [30] Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists
    Paranjape, SB
    Thibonnier, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (05) : 825 - 834